ENvue Medical, Inc. Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease)
ENvue Medical, Inc. (FEED) reported Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) of $6.92 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease · last filed 2021-11-15
- ENvue Medical, Inc. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for the quarter ending 2021-09-30 was $5.67M.
- ENvue Medical, Inc. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for the quarter ending 2021-06-30 was -$705.00K.
- ENvue Medical, Inc. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for the quarter ending 2021-03-31 was $1.95M.
- ENvue Medical, Inc. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for fiscal 2020 was -$513.00.
- ENvue Medical, Inc. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for fiscal 2019 was -$102.00.
| Period end | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) 3 month | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) 6 month | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) 9 month | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) 12 month | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|
| 2021-09-30 | $5.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $4.97M derived: sum of 2 quarters · filed 2021-11-15 | $6.92M 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | -$705.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $1.24M 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | $1.95M 10-Q · filed 2021-05-24 | ||||
| 2020-12-31 | -$513.00 10-K · filed 2021-04-15 | ||||
| 2019-12-31 | -$102.00 10-K · filed 2021-04-15 | -$102.00K 10-K · filed 2020-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |